<DOC>
	<DOCNO>NCT01152255</DOCNO>
	<brief_summary>This study evaluate safety tolerability MK6186 change baseline plasma HIV-1 RNA seven consecutive day dose .</brief_summary>
	<brief_title>MK6186 HIV-1 Infected Patients ( MK-6186-007 AM2 )</brief_title>
	<detailed_description />
	<criteria>Other HIV infection , patient 's baseline health judge stable Patient document HIV1 positive Patient receive investigational agent license ART past 30 day Patient history stroke , chronic seizure , major neurological disease Patient history cancer Patient use immune therapy agent immunosuppressive therapy within past month Patient require anticipates use prescription nonprescription drug study Patient current diagnosis acute hepatitis , history Hepatitis C positive Hepatitis B surface antigen Patient consume excessive amount alcohol ( great 3 serving per day ) caffeine ( great 6 serving per day ) Patient excessive smoker ( 10 cigarette per day ) Patient major surgery , donate blood participate another investigational study within past 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Treatment HIV-1 Infection</keyword>
</DOC>